Linked Life Data

11818397

Source:http://linkedlifedata.com/resource/pubmed/id/11818397

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2002-1-30
pubmed:abstractText
Bactericidal/permeability-increasing protein (BPI), an antibacterial and lipopolysaccharide-neutralizing protein, also has an antiangiogenic effect. To evaluate the therapeutic role of BPI in ischemic retinopathies, the antiangiogenic activity of a human recombinant 21-kDa modified N-terminal fragment of BPI (rBPI(21)), which has the biological properties of the holoprotein, and a peptidomimetic (XMP.Z) derived from BPI were examined.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antimicrobial Cationic Peptides, http://linkedlifedata.com/resource/pubmed/chemical/Blood Proteins, http://linkedlifedata.com/resource/pubmed/chemical/DNA, http://linkedlifedata.com/resource/pubmed/chemical/Endothelial Growth Factors, http://linkedlifedata.com/resource/pubmed/chemical/Lymphokines, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factors, http://linkedlifedata.com/resource/pubmed/chemical/bactericidal permeability...
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0146-0404
pubmed:author
pubmed:issnType
Print
pubmed:volume
43
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
503-9
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:11818397-Animals, pubmed-meshheading:11818397-Antimicrobial Cationic Peptides, pubmed-meshheading:11818397-Blood Proteins, pubmed-meshheading:11818397-Cattle, pubmed-meshheading:11818397-Cells, Cultured, pubmed-meshheading:11818397-DNA, pubmed-meshheading:11818397-Disease Models, Animal, pubmed-meshheading:11818397-Endothelial Growth Factors, pubmed-meshheading:11818397-Humans, pubmed-meshheading:11818397-Infant, Newborn, pubmed-meshheading:11818397-Injections, Intraperitoneal, pubmed-meshheading:11818397-Ischemia, pubmed-meshheading:11818397-Lymphokines, pubmed-meshheading:11818397-Membrane Proteins, pubmed-meshheading:11818397-Mice, pubmed-meshheading:11818397-Mice, Inbred C57BL, pubmed-meshheading:11818397-Peptide Fragments, pubmed-meshheading:11818397-Pericytes, pubmed-meshheading:11818397-Pigment Epithelium of Eye, pubmed-meshheading:11818397-Recombinant Proteins, pubmed-meshheading:11818397-Retinal Neovascularization, pubmed-meshheading:11818397-Retinal Vessels, pubmed-meshheading:11818397-Retinopathy of Prematurity, pubmed-meshheading:11818397-Vascular Endothelial Growth Factor A, pubmed-meshheading:11818397-Vascular Endothelial Growth Factors
pubmed:year
2002
pubmed:articleTitle
Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
pubmed:affiliation
Research Division, Joslin Diabetes Center, Boston, Massachusetts 02215, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't